Brief: Grand Pharmaceutical Says Profit For Year Attributable HK$2,402.56 Million
17/03/2022 14:55
March 17 (Reuters) - Grand Pharmaceutical Group Ltd
0512.HK :
* PROFIT FOR YEAR ATTRIBUTABLE HK$2,402.56 MILLION VERSUS
HK$1,792.66 MILLION
* REVENUE FOR YEAR HK$8,597.98 MILLION VERSUS HK$6,352.92
MILLION
* BOARD PROPOSED A FINAL DIVIDEND OF 11 HK CENTS
Further company coverage: 0512.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement